Moreover, the 36-month beta value for FGEN is 0.74. Analysts have varying opinions on the stock, with 0 analysts rating it as a “buy,” 1 as “overweight,” 1 as “hold,” and 0 as “sell.”
The public float for FGEN is 94.10M and currently, short sellers hold a 5.63% of that float. On March 12, 2025, FGEN’s average trading volume was 3.58M shares.
FGEN) stock’s latest price update
The stock price of FibroGen Inc (NASDAQ: FGEN) has surged by 12.78 when compared to previous closing price of 0.41, but the company has seen a 18.25% gain in its stock price over the last five trading sessions. globenewswire.com reported 2025-03-03 that SAN FRANCISCO, March 03, 2025 (GLOBE NEWSWIRE) — FibroGen, Inc. (NASDAQ: FGEN) will announce fourth quarter and full year 2024 financial results on Monday, March 17 after the markets close. FibroGen will also conduct a conference call on that day at 5:00 PM Eastern Time with the investment community to further detail the company’s corporate and financial performance.
FGEN’s Market Performance
FibroGen Inc (FGEN) has seen a 18.25% rise in stock performance for the week, with a -6.50% decline in the past month and a 36.19% surge in the past quarter. The volatility ratio for the week is 12.24%, and the volatility levels for the past 30 days are at 14.33% for FGEN. The simple moving average for the last 20 days is -3.59% for FGEN stock, with a simple moving average of -19.10% for the last 200 days.
Analysts’ Opinion of FGEN
Many brokerage firms have already submitted their reports for FGEN stocks, with BofA Securities repeating the rating for FGEN by listing it as a “Underperform.” The predicted price for FGEN in the upcoming period, according to BofA Securities is $2 based on the research report published on August 08, 2023 of the previous year 2023.
FGEN Trading at -9.54% from the 50-Day Moving Average
After a stumble in the market that brought FGEN to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -83.36% of loss for the given period.
Volatility was left at 14.33%, however, over the last 30 days, the volatility rate increased by 12.24%, as shares sank -4.52% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -21.57% lower at present.
During the last 5 trading sessions, FGEN rose by +15.25%, which changed the moving average for the period of 200-days by -63.08% in comparison to the 20-day moving average, which settled at $0.4826. In addition, FibroGen Inc saw -12.01% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at FGEN starting from Adib Deyaa, who purchase 22,123 shares at the price of $1.17 back on Jun 12 ’24. After this action, Adib Deyaa now owns 82,123 shares of FibroGen Inc, valued at $25,884 using the latest closing price.
Stock Fundamentals for FGEN
Current profitability levels for the company are sitting at:
- -0.63 for the present operating margin
- 0.77 for the gross margin
The net margin for FibroGen Inc stands at -0.68. The total capital return value is set at -1.53.
Based on FibroGen Inc (FGEN), the company’s capital structure generated -0.65 points at debt to capital in total, while cash flow to debt ratio is standing at -1.59. The debt to equity ratio resting at -0.39. The interest coverage ratio of the stock is -5.35.
Currently, EBITDA for the company is -261.4 million with net debt to EBITDA at 0.49. When we switch over and look at the enterprise to sales, we see a ratio of -0.03. The receivables turnover for the company is 2.16for trailing twelve months and the total asset turnover is 0.68. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.28.
Conclusion
To wrap up, the performance of FibroGen Inc (FGEN) has been mixed in recent times. The stock has received a mixed of “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
